CDK9 and prostate carcinoma: One kinase regulator of AR is cyclin-dependent kinase 9 (CDK9), which phosphorylates AR at serine 81 (pSer81-AR), a modification that enhances AR’s transcriptional activity and prostate cancer cell growth [6, 7].